4//SEC Filing
Alland Leila 4
Accession 0001209191-21-055140
CIK 0001699382other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:22 PM ET
Size
8.7 KB
Accession
0001209191-21-055140
Insider Transaction Report
Form 4
Alland Leila
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-07$3.90/sh+3,900$15,210→ 3,900 total - Sale
Common Stock
2021-09-07$30.25/sh−3,900$117,975→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-09-07−3,900→ 353,950 totalExercise: $3.90Exp: 2030-02-04→ Common Stock (3,900 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.
- [F2]One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter.
Documents
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
Related Parties
1- filerCIK 0001825216
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 4:22 PM ET
- Size
- 8.7 KB